The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Aminoglycoside Resistance in Pseudomonas aeruginosa
Open accessAbstract
Aminoglycosides ([35][1]) are a vital component of antipseudomonal chemotherapy implicated in the treatment of a variety of infections ([9][2], [45][3]), particularly pulmonary infections in cystic fibrosis (CF) patients ([22][4]). These agents are bactericidal and exhibit synergy with other
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AAC may cause gentamicin resistance by transferring the acetyl group to the amino group at the 3′ and 6′ positions of the aminoglycoside.253”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [253]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
Self-citationShifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones
Alexandrakis, G. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00179-2 · Cited by 445
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Galimand, M., Courvalin, P., & Lambert, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2565-2571.2003 · Cited by 350
Hassett, D. J., Cuppoletti, J., Trapnell, B., Lymar, S. V., Rowe, J. J., Sun Yoon, S., Hilliard, G. M., Parvatiyar, K., Kamani, M. C., Wozniak, D. J., et al. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00152-7 · Cited by 313
Gales, A. C., Jones, R. N., Turnidge, J., Rennie, R., & Ramphal, R. (2001) · Clinical Infectious Diseases · doi:10.1086/320186 · Cited by 309
Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei
Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.465 · Cited by 305
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286
Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
AcrD of Escherichia coli Is an Aminoglycoside Efflux Pump
Rosenberg, E. Y., Ma, D., & Nikaido, H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1754-1756.2000 · Cited by 256
Macfarlane, E. L. A., Kwasnicka, A., Ochs, M. M., & Hancock, R. E. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01600.x · Cited by 254
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa
Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H., & Arakawa, Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14959-8 · Cited by 242
Aminoglycoside-modifying enzymes
Wright, G. D. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00007-7 · Cited by 241
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
Jones, M. E., Karlowsky, J. A., Draghi, D. C., Thornsberry, C., Sahm, D. F., & Nathwani, D. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00154-7 · Cited by 227
Nicas, T. I., & Hancock, R. E. W. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.872-878.1980 · Cited by 221
Hancock, R. E., Raffle, V. J., & Nicas, T. I. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.5.777 · Cited by 219
Mathai, D., Jones, R. N., & Pfaller, M. A. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00254-1 · Cited by 216
Macfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
Bouza, E., Juan, R. S., Muñoz, P., Voss, A., & Kluytmans, J. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00326.x · Cited by 201
Pharmacodynamics and dosing of aminoglycosides
Turnidge, J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00057-6 · Cited by 192
Doi, Y., Yokoyama, K., Yamane, K., Wachino, J.-I., Shibata, N., Yagi, T., Shibayama, K., Kato, H., & Arakawa, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.491-496.2004 · Cited by 187
Adaptive Resistance to Aminoglycoside Antibiotics from First-Exposure Down-Regulation
Daikos, G. L., Jackson, G. G., Lolans, V. T., & Livermore, D. M. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.414 · Cited by 181
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 179
Self-citationHocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1371-1375.2003 · Cited by 177
Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition
Azucena, E., & Mobashery, S. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0197 · Cited by 166
Saiman, L., Mehar, F., Niu, W. W., Neu, H. C., Shaw, K. J., Miller, G., & Prince, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.532 · Cited by 164
Hirakawa, H., Nishino, K., Hirata, T., & Yamaguchi, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.6.1851-1856.2003 · Cited by 162
Daikos, G. L., Lolans, V. T., & Jackson, G. G. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.117 · Cited by 158
Edson, R. S., & Terrell, C. L. (1999) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)65134-3 · Cited by 153
Cheer, S. M., Waugh, J., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363220-00015 · Cited by 152
Pitt, T. L. (2003) · Thorax · doi:10.1136/thorax.58.9.794 · Cited by 147
Li, X.-Z., Poole, K., & Nikaido, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.27-33.2003 · Cited by 144
Self-citationVogne, C., Aires, J., Bailly, C., Hocquet, D., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1676-1680.2004 · Cited by 141
Chalita, M. R., Höfling-Lima, A. L., Paranhos, A., Schor, P., & Belfort, R. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00905-x · Cited by 139
Surveillance of antibiotic resistance in European ICUs
Hanberger, H., Diekema, D. J., Fluit, A. C., Jones, R. N., Struelens, M. J., Spencer, R. C., & Wolff, M. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.0987 · Cited by 138
Hoban, D. J., Biedenbach, D. J., Mutnick, A. H., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00540-0 · Cited by 136
A large outbreak of multiresistant Pseudomonas aeruginosa strains in north-eastern Germany
Panzig, B. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.3.415 · Cited by 129
Poirel, L., Girlich, D., Naas, T., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.447-453.2001 · Cited by 129
Shawar, R. M., MacLeod, D. L., Garber, R. L., Burns, J. L., Stapp, J. R., Clausen, C. R., & Tanaka, S. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2877 · Cited by 129
Aminoglycoside Efflux in Pseudomonas aeruginosa : Involvement of Novel Outer Membrane Proteins
Jo, J. T. H., Brinkman, F. S. L., & Hancock, R. E. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1101-1111.2003 · Cited by 125
SHIMIZU, K., 熊田, 徹., Hsieh, W. C., Chung, H. Y., Chong, Y., Hare, R. S., Miller, G. H., Sabatelli, F., & Howard, J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.282 · Cited by 123
Andrade, S. S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg270 · Cited by 117
BpeAB-OprB, a Multidrug Efflux Pump in Burkholderia pseudomallei
Chan, Y. Y., Tan, T. M. C., Ong, Y. M., & Chua, K.-L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1128-1135.2004 · Cited by 116
Mutnick, A. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh039 · Cited by 106
Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis.
Barclay, M. L., Begg, E. J., Chambers, S. T., Thornley, P., Pattemore, P., & Grimwood, K. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.6.1155 · Cited by 105
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.561 · Cited by 102
Schumacher, M. A., & Brennan, R. G. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03039.x · Cited by 101
Sader, H. S., Jones, R. N., Andrade-Baiocchi, S., & Biedenbach, D. J. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00469-8 · Cited by 98
Goossens, H. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00690.x · Cited by 96
Epidemiological studies of aminoglycoside resistance in the U.S.A.
PRICE, K. E., Kresel, P. A., Farchione, L., Siskin, S. B., & Karpow, S. A. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/8.suppl_a.89 · Cited by 96
Edson, R. S., & Terrell, C. L. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.5.519 · Cited by 96
MacLeod, D. L., Nelson, L. E., Shawar, R. M., Lin, B. B., Lockwood, L. G., Dirk, J. E., Miller, G. H., Burns, J. L., & Garber, R. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315312 · Cited by 95
Failure of aminoglycoside antibiotics to kill anaerobic, low-pH, and resistant cultures
Schlessinger, D. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.1.54 · Cited by 87
Mathai, D. C., Lewis, M. T., Kugler, K. C., Pfaller, M. A., & Jones, R. N. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00234-0 · Cited by 82
Mao, W., Warren, M. S., Lee, A. Y., Mistry, A., & Lomovskaya, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2001-2007.2001 · Cited by 82
Turnidge, J. D., Bell, J. M., Biedenbach, D. J., & Jones, R. N. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00050-x · Cited by 74
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates
Shaw, K. J., Hare, R. S., Sabatelli, F., Rizzo, M. F., Cramer, C. A., Naples, L., Kocsi, S., MUNAYYER, H., Mann, P. A., & Miller, G. H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2253 · Cited by 72
Miller, G. H., Sabatelli, F., Naples, L., Hare, R. S., & Shaw, K. J. (1995) · PubMed · Cited by 71
Schülin, T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.403 · Cited by 70
Okamoto, K., Gotoh, N., & Nishino, T. (2002) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0193-7 · Cited by 66
Shahid, M., Malik, A., & Sheeba, S. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00756-0 · Cited by 64
Decousser, J., Pina, P., Picot, F., Delalande, C., Pangon, B., Courvalin, P., & Allouch, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg201 · Cited by 60
Bert, F., Lambert-Zechovsky, N., & Seymour, A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.4.809 · Cited by 59
Lauderdale, T.-L. Y., McDonald, L. C., Shiau, Y., Chen, P., Wang, H., Lai, J., & Ho, M. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2003.10.005 · Cited by 56
Interactions of the major risk factors for coronary heart disease
Gotto, A. M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90160-9 · Cited by 51
Biddlecome, S., Haas, M. J., DAVIES, J. E., Miller, G. H., Rane, D. F., & Daniels, P. J. L. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.6.951 · Cited by 49
Prevalence and mechanisms of aminoglycoside resistance: A ten-year study
Phillips, I. R., King, A., & Shannon, K. P. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90479-1 · Cited by 44
Naas, T., Poirel, L., & Nordmann, P. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00202-x · Cited by 40
Tenover, F. C., Phillips, K. L., Gilbert, T. L., Lockhart, P. G., O’Hara, P. J., & Plorde, J. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.551 · Cited by 40
Galimand, M., Lambert, T., Gerbaud, G., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1456 · Cited by 39
Kazama, H., Kizu, K., Iwasaki, M., Hamashima, H., Sasatsu, M., & Arai, T. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07927.x · Cited by 38
Parr, T. R., & Bayer, A. S. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.5.1003 · Cited by 35
Vliegenthart, J. S., Gaalen, P. A. K.-V., & van de Klundert, J. A. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.892 · Cited by 33
Miller, G. H., Sabatelli, F., Naples, L., Hare, R. S., & Kj, S. (1995) · PubMed · Cited by 32
Sabtcheva, S., Galimand, M., Gerbaud, G., Courvalin, P. M., & Lambert, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1584-1588.2003 · Cited by 29
Aminoglycoside Adaptive Resistance
Karlowsky, J., Zelenitsky, S., & Zhanel, G. (1997) · Pharmacotherapy · doi:10.1002/j.1875-9114.1997.tb03063.x · Cited by 28
Vézina, G., & Lévesque, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.2.313 · Cited by 27
Incidence and mechanisms of aminoglycoside resistance inPseudomonas aeruginosa serotype O11 isolates
Kettner, M., Kallová, J., Hletková, M., & Milosovic, P. (1995) · Infection · doi:10.1007/bf01713571 · Cited by 25
Hurley, J. C., Miller, G. H., & Smith, A. L. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(95)00138-6 · Cited by 24
Resistance to a minoglycosides in Pseudomonas
Groups, A. R. S. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90609-2 · Cited by 20
Prevalence and Mechanisms of Aminoglycoside Resistance
Phillips, I. R., King, A., & Shannon, K. P. (1988) · Cited by 19
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
The antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
Metadata
- Authors
- Poole, K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-02
- Volume
- 49
- Issue
- 2
- Pages
- 479-487
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2117064229
- Cited by
- 470
- References
- 90
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.